When was Nudge founded?

Nudge was founded in 2024 and raised its 1st funding round 1 year after it was founded.

Where is Nudge located?

Nudge is headquartered in San Francisco, United States.

Who is the current CEO of Nudge?

Fred Ehrsam of Nudge. They have also founded 1 company.

Is Nudge a funded company?

Nudge is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Jul 22, 2025.

When was the latest funding round of Nudge?

Nudge's latest funding was a $***** Series A round on Jul 22, 2025, with participation from 2 investors. Its primary sector is Neurology. In United States, the Neurology sector has seen $3.67B in funding in 2026 to date.

Where does Nudge rank among its competitors?

Nudge ranks 1st amongst 84 active competitors, of which 20 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Imaginostics, which secured $40K in May, 2026.

Who are the top competitors of Nudge?

Nudge's top competitors include VISIE, Panaxium and Darmiyan. Among them, Imaginostics secured the most recent funding round in May, 2026.

Nudge - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of whole-brain interfaces intended to improve human-brain interaction. It offers a phased-array ultrasound-based wearable device capable of both imaging and modulating brain activity aiming to enable at-home devices for mood, memory, focus, or treating chronic conditions like pain, addiction, and anxiety.

Website: nudge.com
Social
Email ID: *****@nudge.com

Key Metrics

Founded Year

2024

Location

San Francisco, United States

Stage

Series A

Total Funding

$100M in 1 round

Latest Funding Round

Series A, Jul 22, 2025, $*****

Investors

Thrive Capital & 1 more

Ranked

1^st among 84 active competitors

Similar Companies

VISIE & 91 more

View Nudge's full profile

Nudge has raised a total funding of $100M over 1 round. Its latest funding round was a Series A round on Jul 22, 2025 for $*****. 2 investors participated in its latest round. Nudge has 2 institutional investors.

Here is the list of recent funding rounds of Nudge:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 22, 2025	8457323	Series A	8327139	6047487	5048374	7793021

Access funding benchmarks and valuations. Sign up today!

View details of Nudge's funding rounds and investors

The founders of Nudge are Fred Ehrsam and Quintin Frerichs. Fred Ehrsam is the CEO of Nudge.

Here are the details of Nudge's key team members:

Fred Ehrsam: Co-Founder & CEO of Nudge.
Contact Info: 1 email address
Quintin Frerichs: Co-Founder of Nudge.
Contact Info: 1 email address

View details of Nudge's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nudge include VISIE, Panaxium and Darmiyan. Here is the list of Top 10 competitors of Nudge, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Nudge 2024, San Francisco (United States), Series A	Developer of whole-brain interfaces intended to improve human-brain interaction	$100M	Thrive Capital, Greenoaks	55/100
2nd	VISIE 2017, Austin (United States), Series A	Provider of 3D intraoperative imaging technology for orthopedic, neuro, and spine surgery	$12.7M	Capital Factory, Flat Rock Global & 7 others	54/100
3rd	Panaxium 2016, Aix-en-Provence (France), Seed	Developer of medical equipment for surgeons and neurologists to treat brain injuries	-	Ontario Brain Institute, Europa & 1 others	53/100
4th	Darmiyan 2015, San Francisco (United States), Seed	Platform for presymptomatic diagnosis of neurodegenerative disorders	$10.1M	Eisai Innovation, Camford Capital & 11 others	53/100
5th	Inscopix 2011, Palo Alto (United States), Acquired	Platform specialized in developing miniscope platforms for decoding brain neural circuits	$11.5M	Playground Global, AME Cloud Ventures & 2 others	52/100
6th	Imaginostics 2011, Cambridge (United States), Series A	Provider of solution for magnetic resonance imaging biomarkers for diagnosis of neurological disorder	$7.64M	Ideaship, HHS & 2 others	51/100
7th	Burl Concepts 2013, San Diego (United States), Series C	Developer of a portable ultrasound device for stroke detection	$10.4M	Acquipharma Holdings	45/100
8th	QuantalX NeuroScience 2014, Ness Ziona (Israel), Funding Raised	Provider of AI-based diagnostic software for brain diseases	-	Ludicrous Ventures	44/100
9th	Cortirio 2017, London (United Kingdom), Seed	Developer of smart devices for neurological disorders management	-	o2h ventures, FLOBAS Ventures & 17 others	43/100
10th	Araya Brain Imaging 2013, Chiyoda City (Japan), Series B	Neuroimaging technology and services	$9.3M	31VENTURES, Sumitomo Shoji Machinex Co.,Ltd. ... & 7 others	41/100